Using different statistical tools, we identified variants associated with the etiology of cancer having differential mutation prevalence across tumor grades with MUC20, TP53, and RUNX1T1 higher in grade 3 tumors, while PIK3CA and CBFB were higher in grade 1 tumors (Additional file 1: Table S1). This evidence concerns the gene TP53 and cancer.